4[1]Jarvis WR.Epidemiology of nosocomial fungal infection with emphasis on Candida species[J].Clin Infect Dis,1995,20(6): 1526-1530.
5[5]Kondoh Y,Shimizu K,Tanaka K et al.Proteinase production and pathogenicity of Candida albicans.Ⅱ Virulence for mice of C.albicans strains of different proteinase activity[J].Microbiol Immunol,1987,31(11): 1045-1060.
6[12]Ollert MW,Wende C,Gorlich M,et al.Increased expression of Candida albicans secretory proteinase,a putative virulence factor,in isolates from human immunodeficiency virus-positive patients[J].J Clin Microbiol,1995,33: 2543-2549.
7[13]Ray TL,Payne CD.Comparative production and rapid purification of Candida albicans acid proteinase from protein-supplemented cultures[J].Infect Immun,1990,58(2): 508-514.
8[14]Ruchel R,Tegeler R,Trost M,et al.A comparison of secretory proteinase from different strains of Candida albicans[J].J Med Vet Mycol,1982,20: 233-244.
9Wada S, NiimiM, NiimiM, et al. Candida glabrata ATP-binding cassette transporters Cdrlp and Pdhlp espressed in a Saccharomyces cerevisiae steai deficient in membrane transporters show phorylation dependent pumping properties [J]. J Biolcham, 2002, 277 (48) : 46809.
10Kontoyiannis DP, Lewis Antifungal drug resistance of pathogenic fungi [J]. Lancet, 2002, 359 (9312): 1135.
